BRIEF published on 11/26/2025 at 00:51, 8 months 10 days ago CureVac annonce les résultats de son assemblée générale extraordinaire Assemblée Générale Extraordinaire BioNTech Approbation Des Actionnaires CureVac Fusion Légale
BRIEF published on 11/26/2025 at 00:51, 8 months 10 days ago CureVac Announces Results of Extraordinary General Meeting BioNTech Extraordinary General Meeting CureVac Shareholders Approval Legal Merger
PRESS RELEASE published on 11/26/2025 at 00:46, 8 months 10 days ago CureVac Announces Voting Results of Extraordinary General Meeting CureVac announces approval of BioNTech's exchange offer for outstanding shares at Extraordinary General Meeting with over 99.16% approval rate BioNTech MRNA Technology Exchange Offer CureVac EGM Voting Results
BRIEF published on 11/24/2025 at 13:15, 8 months 12 days ago CureVac publie ses résultats financiers du troisième trimestre et des neuf premiers mois de 2025 Performance Financière CureVac Technologie De L'ARNm Résultats Du Troisième Trimestre 2025 Fusion BioNTech
BRIEF published on 11/24/2025 at 13:15, 8 months 12 days ago CureVac Reports Q3 and Nine-Month Financial Results for 2025 Financial Performance MRNA Technology CureVac Q3 2025 Results BioNTech Merger
PRESS RELEASE published on 11/24/2025 at 13:10, 8 months 12 days ago CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates CureVac announces financial results for Q3 and first nine months of 2025, BioNTech transaction progresses, EMA clearance received for cancer therapy CVHNLC sqNSCLC Financial Results Cancer Therapy CureVac BioNTech Transaction EMA Clearance
BRIEF published on 08/15/2025 at 13:32, 11 months 22 days ago CureVac Reports Q2 and H1 2025 Financial Results; Announces Key Developments Financial Results MRNA Technology CureVac Patent Resolution BioNTech Acquisition
BRIEF published on 08/15/2025 at 13:32, 11 months 22 days ago CureVac publie ses résultats financiers du deuxième trimestre et du premier semestre 2025 et annonce des développements clés Résultats Financiers CureVac Technologie De L'ARNm Résolution De Brevet Acquisition De BioNTech
PRESS RELEASE published on 08/15/2025 at 13:27, 11 months 22 days ago CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac announces Q2 2025 financial results, business updates & agreement with BioNTech for transformative mRNA treatments. Strong cash position Financial Results BioNTech CureVac MRNA Q2 2025
BRIEF published on 08/08/2025 at 02:20, 11 months 29 days ago CureVac Settles Patent Dispute with Pfizer/BioNTech MRNA Technology CureVac Pfizer/BioNTech Patent Resolution Vaccine Royalties
Published on 08/06/2026 at 14:00, 35 minutes ago Adcore to Publish Second Quarter 2026 Results on August 13, 2026
Published on 08/06/2026 at 14:00, 35 minutes ago Aeonian Reports Final Drill Results from Jake Target and Advances District-Scale Copper Exploration Model at Koocanusa
Published on 08/06/2026 at 14:00, 35 minutes ago GameSquare Signs with Azuki to Drive Creator Marketing for Gates Awakened TCG Launch and Manga Launch
Published on 08/06/2026 at 13:35, 1 hour ago Silver X Mining Corp. Reports Record 2Q26 Revenue of $17.3M, up 29% over 1Q26, and $7.7M of First-Half Net Income
Published on 08/06/2026 at 13:30, 1 hour 5 minutes ago Nextech3D.ai Expands Enterprise Customer Base, Generating $874,000 in New Contract Value, 160 New Customer Contracts and 92% Software Gross Margins in 2026
Published on 08/06/2026 at 14:01, 34 minutes ago Original-Research: DEUTZ AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 08/06/2026 at 14:00, 35 minutes ago The NAGA Group: NuWays confirms “Buy” rating and price target of EUR 7.30
Published on 08/06/2026 at 13:00, 1 hour 35 minutes ago Fresenius transitions to registered shares – automatic conversion for shareholders
Published on 08/06/2026 at 08:44, 5 hours 50 minutes ago IDI annonce la cession du groupe Talis à son fondateur, Serge Marcillaud, accompagné de l'équipe dirigeante
Published on 08/06/2026 at 08:00, 6 hours 35 minutes ago EURAZEO ENTRE EN DISCUSSIONS EXCLUSIVES AVEC PARTNERS GROUP EN VUE DE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET DE SON RÉINVESTISSEMENT À SES CÔTÉS
Published on 08/06/2026 at 08:00, 6 hours 35 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/06/2026 at 07:48, 6 hours 46 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 18:00, 20 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
